Login / Signup

Clinical outcomes of hepatitis C virus elimination using glecaprevir and pibrentasvir in hemodialysis patients: A multicenter study.

Akihiro MorishitaChikara OgawaAkio MoriyaJoji TaniHirohito YoneyamaKoji FujitaMakoto OryuTomonori SenooKoichi TakaguchiTsutomu Masaki
Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)
HCV elimination using glecaprevir/pibrentasvir treatment might be a major breakthrough for the control of anemia in hemodialysis patients.
Keyphrases
  • hepatitis c virus
  • human immunodeficiency virus
  • chronic kidney disease
  • iron deficiency
  • hiv infected